Summary
Zhen Zhang is a statistician and leader with 10+ years driving innovative biostatistics and RWD strategies across phase I–IV drug development and preclinical programs at major pharma companies. As Director at Otsuka he leads a cross-functional statistics team supporting late‑phase studies, RWE, medical affairs, regulatory/HTA dossiers and economic modeling across CNS, nephrology and medical devices. His background includes designing adaptive and Bayesian trials, platform/seamless designs, and borrowing historical controls for submissions at Pfizer, Eisai and Lilly, plus earlier AI/ML-driven predictive toxicology work at DowDuPont. He combines deep quantitative training (PhD, postdoc in statistics) with hands-on implementation of novel Bayesian and spatial methods and practical experience managing CROs, vendors and biomarker/neuroimaging workflows. Notably, he has bridged methodological research and regulatory impact—leading grant-funded Bayesian design work and analyses that supported FDA submissions.
10 years of coding experience
4 years of employment as a software developer
Bachelor's degree Mathematics, Bachelor's degree Mathematics at Shanghai Jiao Tong University
Postdoctoral scholar Statistics, Postdoctoral scholar Statistics at University of Chicago
Doctor of Philosophy (Ph.D.) Statistics, Doctor of Philosophy (Ph.D.) Statistics at Michigan State University
Chinese, English, Japanese